Oral Pyrophosphate Absorption in PXE Disease

NCT04441671 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Withdrawn

Conditions

Interventions

Sponsor

Tampere University Hospital

Collaborators